Derek Mendy
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in
-
- Protein Degradation and Inhibitors 15
- Ubiquitin and proteasome pathways 9
- Histone Deacetylase Inhibitors Research 4
- Hematology 16
- Multiple Myeloma Research and Treatments 16
- Co-authors
- Antonia Lopez‐Girona (20 shared papers)Peter Schäfer (10 shared papers)Anita K. Gandhi (8 shared papers)Rajesh Chopra (11 shared papers)Svetlana Gaidarova (6 shared papers)Tom Daniel (7 shared papers)Brian E. Cathers (8 shared papers)Emily Rychak (9 shared papers)
- Journals
- Blood (12 papers)British Journal of Haematology (3 papers)Leukemia (1 paper)Current Cancer Drug Targets (1 paper)Hematological Oncology (1 paper)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Derek Mendy
21 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Hematology 771
- Oncology 518
- Molecular Biology 1.1k
- Genetics 96
- Pathology and Forensic Medicine 131
Countries citing papers authored by Derek Mendy
This map shows the geographic impact of Derek Mendy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Mendy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Mendy more than expected).
Fields of papers citing papers by Derek Mendy
This network shows the impact of papers produced by Derek Mendy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Mendy. The network helps show where Derek Mendy may publish in the future.
Co-authors
The 25 scholars most cited alongside Derek Mendy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide Hit paper breakdown → | 2012 | 606 |
| 2 | 2008 | 220 | |
| 3 | 2010 | 142 | |
| 4 | 2011 | 137 | |
| 5 | 2013 | 71 | |
| 6 | 2018 | 56 | |
| 7 | 2016 | 40 | |
| 8 | 2019 | 18 | |
| 9 | 2019 | 16 | |
| 10 | 2010 | 9 | |
| 11 | 2012 | 8 | |
| 12 | 2009 | 5 | |
| 13 | 2021 | 4 | |
| 14 | 2011 | 4 | |
| 15 | 2013 | 3 | |
| 16 | 2008 | 3 | |
| 17 | 2022 | 2 | |
| 18 | 2013 | 1 | |
| 19 | 2009 | 1 | |
| 20 | 2012 | 1 |
About Derek Mendy
Derek Mendy is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (16 papers), Protein Degradation and Inhibitors (15 papers), Ubiquitin and proteasome pathways (9 papers), Histone Deacetylase Inhibitors Research (4 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), CAR-T cell therapy research (2 papers) and Fungal Plant Pathogen Control (1 paper). The work is most often cited by research in Hematology (771 citations), Oncology (518 citations), Molecular Biology (1.1k citations), Genetics (96 citations) and Pathology and Forensic Medicine (131 citations). Derek Mendy has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Antonia Lopez‐Girona, Peter Schäfer, Anita K. Gandhi, Rajesh Chopra, Svetlana Gaidarova, Tom Daniel, Brian E. Cathers, Emily Rychak, Mahan Abbasian and Gilles Carmel. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Current Cancer Drug Targets and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.